201 related articles for article (PubMed ID: 16005983)
1. Patient-based utilities for bipolar disorder-related health states.
Revicki DA; Hanlon J; Martin S; Gyulai L; Nassir Ghaemi S; Lynch F; Mannix S; Kleinman L
J Affect Disord; 2005 Aug; 87(2-3):203-10. PubMed ID: 16005983
[TBL] [Abstract][Full Text] [Related]
2. Patient utilities in fibromyalgia and the association with other outcome measures.
Bakker C; Rutten M; van Santen-Hoeufft M; Bolwijn P; van Doorslaer E; Bennett K; van der Linden S
J Rheumatol; 1995 Aug; 22(8):1536-43. PubMed ID: 7473480
[TBL] [Abstract][Full Text] [Related]
3. Health state utilities for childhood attention-deficit/hyperactivity disorder based on parent preferences in the United kingdom.
Secnik K; Matza LS; Cottrell S; Edgell E; Tilden D; Mannix S
Med Decis Making; 2005; 25(1):56-70. PubMed ID: 15673582
[TBL] [Abstract][Full Text] [Related]
4. Quetiapine monotherapy in the treatment of depressive episodes of bipolar I and II disorder: Improvements in quality of life and quality of sleep.
Endicott J; Paulsson B; Gustafsson U; Schiöler H; Hassan M
J Affect Disord; 2008 Dec; 111(2-3):306-19. PubMed ID: 18774180
[TBL] [Abstract][Full Text] [Related]
5. Patient utilities in ankylosing spondylitis and the association with other outcome measures.
Bakker C; Rutten-van Mölken M; Hidding A; van Doorslaer E; Bennett K; van der Linden S
J Rheumatol; 1994 Jul; 21(7):1298-304. PubMed ID: 7966073
[TBL] [Abstract][Full Text] [Related]
6. Long-term effectiveness and cost of a systematic care program for bipolar disorder.
Simon GE; Ludman EJ; Bauer MS; Unützer J; Operskalski B
Arch Gen Psychiatry; 2006 May; 63(5):500-8. PubMed ID: 16651507
[TBL] [Abstract][Full Text] [Related]
7. Differences between subjective and objective assessments of the utility of Electroconvulsive therapy in patients with bipolar and unipolar depression.
Hallam KT; Smith DI; Berk M
J Affect Disord; 2009 Jan; 112(1-3):212-8. PubMed ID: 18501434
[TBL] [Abstract][Full Text] [Related]
8. The Bipolar Depression Rating Scale (BDRS): its development, validation and utility.
Berk M; Malhi GS; Cahill C; Carman AC; Hadzi-Pavlovic D; Hawkins MT; Tohen M; Mitchell PB
Bipolar Disord; 2007 Sep; 9(6):571-9. PubMed ID: 17845271
[TBL] [Abstract][Full Text] [Related]
9. Comparing diagnostic checklists for pediatric bipolar disorder in academic and community mental health settings.
Youngstrom E; Meyers O; Demeter C; Youngstrom J; Morello L; Piiparinen R; Feeny N; Calabrese JR; Findling RL
Bipolar Disord; 2005 Dec; 7(6):507-17. PubMed ID: 16403176
[TBL] [Abstract][Full Text] [Related]
10. Health-related quality of life and functioning in remitted bipolar I outpatients.
Piccinni A; Catena M; Del Debbio A; Marazziti D; Monje C; Schiavi E; Mariotti A; Bianchi C; Palla A; Roncaglia I; Carlini M; Pini S; Dell'Osso L
Compr Psychiatry; 2007; 48(4):323-8. PubMed ID: 17560952
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of quetiapine monotherapy in rapid-cycling bipolar disorder in comparison with sodium valproate.
Langosch JM; Drieling T; Biedermann NC; Born C; Sasse J; Bauer H; Walden J; Bauer M; Grunze H
J Clin Psychopharmacol; 2008 Oct; 28(5):555-60. PubMed ID: 18794653
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of quetiapine monotherapy in bipolar I and II depression: a double-blind, placebo-controlled study (the BOLDER II study).
Thase ME; Macfadden W; Weisler RH; Chang W; Paulsson B; Khan A; Calabrese JR;
J Clin Psychopharmacol; 2006 Dec; 26(6):600-9. PubMed ID: 17110817
[TBL] [Abstract][Full Text] [Related]
13. Impact of anxiety disorder comorbidity on quality of life in euthymic bipolar disorder patients: differences between bipolar I and II subtypes.
Albert U; Rosso G; Maina G; Bogetto F
J Affect Disord; 2008 Jan; 105(1-3):297-303. PubMed ID: 17617468
[TBL] [Abstract][Full Text] [Related]
14. Utility assessment among patients with dry eye disease.
Schiffman RM; Walt JG; Jacobsen G; Doyle JJ; Lebovics G; Sumner W
Ophthalmology; 2003 Jul; 110(7):1412-9. PubMed ID: 12867401
[TBL] [Abstract][Full Text] [Related]
15. Augmentative repetitive navigated transcranial magnetic stimulation (rTMS) in drug-resistant bipolar depression.
Dell'Osso B; Mundo E; D'Urso N; Pozzoli S; Buoli M; Ciabatti M; Rosanova M; Massimini M; Bellina V; Mariotti M; Altamura AC
Bipolar Disord; 2009 Feb; 11(1):76-81. PubMed ID: 19133969
[TBL] [Abstract][Full Text] [Related]
16. Concordance of self-rated and observer-rated dysphoric symptoms in mania.
Cassidy F; Ahearn E; Carroll BJ
J Affect Disord; 2009 Apr; 114(1-3):294-8. PubMed ID: 18684512
[TBL] [Abstract][Full Text] [Related]
17. Utility measures of health-related quality of life in patients treated for benign paroxysmal positional vertigo.
Roberts RA; Abrams H; Sembach MK; Lister JJ; Gans RE; Chisolm TH
Ear Hear; 2009 Jun; 30(3):369-76. PubMed ID: 19322083
[TBL] [Abstract][Full Text] [Related]
18. Social anxiety symptoms across diagnoses among outpatients attending a tertiary care mood and anxiety disorders service.
Graystone HJ; Garner MJ; Baldwin DS
J Affect Disord; 2009 Apr; 114(1-3):305-9. PubMed ID: 18656267
[TBL] [Abstract][Full Text] [Related]
19. Quetiapine monotherapy in the treatment of patients with bipolar I or II depression and a rapid-cycling disease course: a randomized, double-blind, placebo-controlled study.
Vieta E; Calabrese JR; Goikolea JM; Raines S; Macfadden W;
Bipolar Disord; 2007 Jun; 9(4):413-25. PubMed ID: 17547587
[TBL] [Abstract][Full Text] [Related]
20. Obese versus non-obese patients with type 2 diabetes: patient-reported outcomes and utility of weight change.
Matza LS; Yurgin N; Boye KS; Malley K; Shorr JM
Curr Med Res Opin; 2007 Sep; 23(9):2051-62. PubMed ID: 17651535
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
